نتایج جستجو برای: HDL- C وapoA-I
تعداد نتایج: 1966907 فیلتر نتایج به سال:
abca1 عضوی از خانواده بزرگ ناقل های غشایی abc (انتقال دهندههای جعبهای متصل به atp) در پستانداران است که نقشی اساسی در نوآراییhdl-c و پیشگیری از بیماری آترواسکلروزیس(تصلب شرائین) دارد. هدف از پژوهش حاضر بررسی تغییرات abca1 کبدی و سطوح پلاسمایی hdl-c موشهای نرویستار به دنبال چهار هفته تمرین مقاومتی است. 16 موش صحرایی نر ویستار 14-12 هفته ای با میانگین وزن10±290 گرم در این پژوهش مورد استفاده قرار ...
ABCA1 عضوی از خانواده ناقل‌های غشایی ABC در پستانداران است که نقشی اساسی در نوآراییHDL-C و پیشگیری از بیماری آترواسکلروزیس (تصلب شرائین) دارد. هدف از پژوهش بررسی تغییرات ABCA1 کبدی و سطوح پلاسمایی HDL-C موشهای نرویستار به دنبال چهار هفته تمرین مقاومتی است. 16 موش صحرایی نر ویستار 14-12 هفته‌ای با میانگین وزن290 گرم در دو گروه کنترل (8n=) و تمرین (8n=) در این پژوهش مورد استفاده قرار گرفت. تمرین...
Clinical studies indicate that levels of apolipoprotein A-I (apo A-I), the major protein moiety of the high density lipoprotein (HDL) particle, may provide more information concerning the risk of future cardiovascular disease than do levels of HDL cholesterol (HDL-C). Therefore, the relationship of HDL-C to apo A-I levels was examined in a biracial sample of 2849 5- to 17-year-olds. The mean HD...
OBJECTIVE Low HDL cholesterol (HDL-C) and small HDL particle size may directly promote hyperglycemia. We evaluated associations of HDL-C, apolipoprotein A-I (apoA-I), and HDL-C/apoA-I with insulin secretion, insulin resistance, HbA1c, and long-term glycemic deterioration, reflected by initiation of pharmacologic glucose control. RESEARCH DESIGN AND METHODS The 5-year Fenofibrate Intervention ...
BACKGROUND Chemically measured high-density lipoprotein cholesterol (HDL-C) may not be the best clinical measure of HDL. Little is known about alternative HDL measures such as HDL size or particle number (HDL-P) as determinants of residual risk after potent statin therapy. METHODS AND RESULTS In Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin ...
BACKGROUND The contribution of apolipoprotein A-I (apoA-I) to coronary heart disease (CHD) risk stratification over and above high-density lipoprotein cholesterol (HDL-C) is unclear. We studied the associations between plasma levels of HDL-C and apoA-I, either alone or combined, with risk of CHD events and cardiovascular risk factors among apparently healthy men and women. METHODS AND RESULTS...
BACKGROUND AND AIMS High-density lipoproteins (HDLs) may directly stimulate β-cell function and glucose metabolism. We determined the relationships of fasting high-density lipoprotein cholesterol (HDL-C), plasma apolipoprotein (apo) A-I and apoA-II, and HDL-C-to-apoA-I and HDL-C-to-apoA-II ratios, as estimates of HDL particle composition, with incident type 2 diabetes mellitus. METHODS A pros...
BACKGROUND HDL size and composition vary among individuals and may be associated with cardiovascular disease and diabetes. We investigated the theoretical relationship between HDL size and composition using an updated version of the spherical model of lipoprotein structure proposed by Shen et al. (Proc Natl Acad Sci U S A 1977;74:837-41.) and compared its predictions with experimental data from...
High density lipoproteins (HDLs) and their subspecies play a role in the development of coronary heart disease (CHD). HDL subpopulations were measured by 2-dimensional nondenaturing gel electrophoresis in 79 male control subjects and 76 male CHD patients to test the hypothesis that greater differences in apolipoprotein (apo)A-I-containing HDL subpopulations would exist between these 2 groups th...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید